The overall quality of chronic pain management in the United States is woefully poor, and unfortunately getting worse. Schatman and Fortino recently elucidated many of the causes of this deterioration, 1 although revisiting these deficiencies is beyond the scope of this analysis. As a result of this state, neither patients nor healthcare providers who treat those with chronic pain are particularly satisfied. For example, patients are likely to see themselves as being treated in a system in which their voices are progressively less likely to be heard, where there is a lack of communication and responsiveness, a lack of comprehensive pain care, and rushed visits. 2 On the other hand, providers are dissatisfied by issues including a lack of resources for providing adequate treatment(s), unrealistic patient expectations for pain relief, and their own inadequate educations regarding pain management. 3 COVID-19 has certainly not helped improve the quality of chronic pain management. Much has been written over the past year and a half regarding the effect of the pandemic on treatment that patients have received. The early literature addressed the use of telehealth to provide behavioral services to chronic pain patients, 4 along with best practices consensus statements, which were focused on interventional pain medicine. 5,6 Progressively, other issues were addressed, including the impact of the pandemic on fellowship training, 7 the safety of various medications during COVID-19, 8-10 the risks of developing chronic pain as a result of COVID-19 infection and treatment, 11 manifestations of characterological disturbances among chronic pain sufferers triggered by the pandemic, 12 dealing with disruptions of research on pain management due to the pandemic, 13 the implications of postponed joint replacement surgeries for pain management, 14 the impact of social distancing and other COVID-19-related phenomena on psychosocial aspects of chronic pain, 15,16 the impact of the redeployment of clinical staff from pain management departments due to the pandemic, 17 and the effect of the pandemic on the opioid epidemic, 18,19 among several other areas of investigation. The focus of the extant medical literature on pain patient well-being and threats to it is certainly appropriate. Glaringly absent, however, in a thorough review of the literature are articles addressing the impact of COVID-19 on providers of chronic pain management services. Amidst myriad adjustments observed in pain management practices across the US as a result of the COVID-19 pandemic, this analysis aims to underscore the